Key facts
- This page summarizes Bjoern Klaas's Form 4 filing for Proto Labs Inc (PRLB).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 15 Feb 2023, 15:05.
Bjoern Klaas - 13 Feb 2023 Form 4 Insider Report for Proto Labs Inc (PRLB)
- Reporting relationship
- VP and Mng Director-PL Europe
- Issuer ticker
- PRLB
- Reported as of
- 13 Feb 2023
- Net transaction value
- -$38,303
- SEC form
- 4
- Accepted by SEC
- 15 Feb 2023, 15:05:34 UTC
- Prior SEC filing
- 17 Feb 2022
- Next SEC filing
- 15 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ W. Morgan Burns, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bjoern Klaas filed Form 4 for Proto Labs Inc (PRLB) on 15 Feb 2023.
Change
- Previous filing in this sequence was filed on 17 Feb 2022.
- Current net transaction value: -$38,303.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PRLB
transaction
Common Stock
Tax liability
- Transaction value
- $38,303
- Shares
- -1,119
- Change %
- -8.9%
- Price
- $34.23
- Shares after
- 11,425
- Date
- 13 Feb 2023
- Ownership
- Direct
PRLB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +6,649
- Change %
- +58%
- Price
- $0.000000
- Shares after
- 18,074
- Date
- 14 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PRLB
transaction
Derivative
Performance Stock Units
Award
- Transaction value
- $0
- Shares
- +3,325
- Change %
- Price
- $0.000000
- Shares after
- 3,325
- Date
- 14 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,325
- Exercise price
- Footnotes
- F2
PRLB
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +6,310
- Change %
- Price
- $0.000000
- Shares after
- 6,310
- Date
- 14 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,310
- Exercise price
- $33.84
- Footnotes
- F3
PRLB
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +3,048
- Change %
- Price
- $0.000000
- Shares after
- 3,048
- Date
- 14 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,048
- Exercise price
- $33.84
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.
Footnote F2
Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share.
Footnote F3
25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.
Footnote F4
The stock option vests in full on February 13, 2024.